MedTrace Logo

Study of RV Remodeling in Congenital Heart Disease

NCT02791061 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2017-03-31

No results posted yet for this study

Summary

The primary aims of this study are to 1. Develop an automated method of quantitation of RV remodeling in terms of regional RV surface curvature and area strain and assess the feasibility, repeatability and accuracy in normal subjects and patients with repaired TOF, patients with PS

The secondary study aims of this study are to

1\. Compare the differences of RV remodeling in repaired TOF patients, PS patients with sex and age-matched controls 2, Assess the relationship of our proposed parameters to global RV function and exercise capacity in repaired TOF patients and PS patient

Conditions

  • Congenital Heart Disease

Interventions

OTHER

Cardiovascular Magnetic Resonance Imagine (MRI)

MRI uses interaction of the magnetic properties of body tissues with strong magnetic fields to create images.

OTHER

Cardiopulmonary exercise testing (CPET)

Cardiopulmonary exercise testing (CPET) is non-invasive simultaneous measurement of the cardiovascular and respiratory system during exercise to assess a patient's exercise capacity.

OTHER

Echocardiography

To measure heart chamber size, heart function, blood vessel size and blood vessel function. These measurements will help us understand the type and severity of heart failure.

Sponsors & Collaborators

  • National Heart Centre Singapore

    lead OTHER

Principal Investigators

  • Ru San Tan, MBBS · National Heart Centre Singapore

Eligibility

Min Age
13 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02791061 on ClinicalTrials.gov